All the Drug Class Drugs
ACE Inhibitor. Captopril 12.5, 25, 50 mg. TABS: 90 x 12.5mg, 25mg, 50mg.
Max. dly. dose: 150 mg. Hypertens: Initial: 25-50 mg 2 x dly in div. doses. Incr.
intervals at least 2 wks: 100-150 mg dly in div. doses to reach target BP.
Heart fail.: Init.: 12.5 mg BID or TID.
Titrat. to maint. dose (75-150 mg dly) at intervals of at least 2 wks. depen. on pt. response.
Type 1 diabet. nephropathy: 75-100 mg dly in div doses.
MI, ren. impair., elderly: See lit.
Hypertens., C.H.F., insulin depend. diabet. nephropathy in hypertens./nonhypertens. pts. when serum creatinine level < 2.5 mg/dl. Improve survival follow. MI in clinic. stable pts. with left ventric. dysfunct. manifest. as eject. fract. < or equals 40% and to reduce incidence of overt heart fail. and subseq. hospitalizat. for C.H.F. in these pts.
C/I: Hypersens. Hypersens. to other ACE inhib.
Hist. of angioedema assoc. with previous ACE-inhib. ther., hered. idiopath. angioedema. 2nd, 3rd trim. of preg.
Concom. use with aliskiren contain. product in pts. with diab. mell. or renal impair. (GFR <60ml/min/1.73 m2). See lit.
ACE Inhibitor. Cilazapril 1, 2.5, 5 mg. TABS: 28 x 1 mg, 2.5 mg, 5 mg. Essent.
hypertens: 1.25 mg 1 x dly for first 2
days. Maint: 2.5-10 mg 1 x dly. adjust.
accord. pt. response. Renovasc. hypertens.
Initial: 0.5 mg 1 x dly. under close
med. vision. Maint: Accord. to
response. C.H.F: Initial: 1 mg dly.
Maint: 1 - 2.5 mg 1 x dly. Adjust.
accord. pt. response.
Essential and renal hypertens., C.H.F.
C/I: Ascites, pregn., lact.
ACE Inhibitor, Thiazide. Cilazapril 5 mg, Hydrochlorothiazide 12.5 mg. TABS: 28. 1 tab dly.
Essential hypertens. in patients who
have been stabilized on individual
components given in the same
proportions.
C/I: Pregn., lact.
ACE Inhibitor. Enalapril Maleate 5, 10, 20 mg. TABS: 30x5mg, 10mg, 20mg. Hypertens.: Initial: usually 5-20 mg 1 x dly. Dose of 5 mg or lower may be indicated in cases such as strongly activated renin-angiotensin-aldosterone syst. prior tmt. with high doses diuretics. See lit. Mainten.: usually 20 mg dly, max. maint. dose: 40 mg dly.
HF/asymptom. left ventr. dysfunct.: Initial 2.5 mg, incr. gradual.
Mainten.: 20mg in single dose/2 div. doses. Max: 40mg in 2 div. doses. See lit.
For dosage in renal insuffic./elderly/paediatrics: see lit.
Tmt. of essent. hypertens., renovasc. hypertens., CHF, to reduce mortal. in all degrees HF. To retard develop. of symptom. HF In asymptom. pts. with left ventric. dysfunc.
C/I: Hypersens. Hypersens. to other ACE inhib.; hist. of angioedema assoc. with previous ACE-inhib. ther., hered. idiopath. angioedema; 2nd, 3rd trim. of preg.; concom. use with aliskiren contain. product in pts. with diab. mell. or renal impair. (GFR <60ml/min/1.73 m2); comb. with sacubitril/valsartan.
Administrat. of enalapril within 36 hrs. of switching to or from sacubitril/valsartan. See lit.
ACE Inhibitor. Enalapril Maleate 5, 10, 20 mg. TABS: 30. See lit.
Essential hypertens., renovasc.
hypertens., CCF, reduce mortality in pts.
with all degrees heart fail., retard
develop. sympt. heart fail. in asympt. pts.
with left ventric. dysfunct.
ACE Inhibitor, Calcium Channel Blocker. Lercanidipine HCl 10, Enalapril Maleate 10, 20. FC Tabs: 10 mg/10 mg, 10mg/20mg. Tmt. of essent. hypertens. in pts. not contr. by lercanadipine monother.
C/I: See lit.